Oxybutynin
Links shared publicly online about this topic
MediGuard - Oxybutynin View
mediguard.org — “MediGuard - Oxybutynin View” View full resource at mediguard.org
Most Recently Shared on July 28, 2010 at 1:17 am By:
MediGuard.org Health Organization
41% of #oxybutynin users getting side-effects ... http://tinyurl.com/356u76p
iGuard.org - Oxybutynin Drug Interactions, Oxybutynin Side Effects and Oxybutynin Patient Reviews
iguard.org — “iGuard.org - Oxybutynin Drug Interactions, Oxybutynin Side Effects and Oxybutynin Patient Reviews” View full resource at iguard.org
Most Recently Shared on July 28, 2010 at 1:17 am By:
MediGuard.org Health Organization
Approx 35% of #oxybutynin users experiencing dryness: http://tinyurl.com/356u76p
Immediate-Release Oxybutynin for the Treatment of Clozapine-Induced Sialorrhea (September)
theannals.com — “Immediate-Release Oxybutynin for the Treatment of Clozapine-Induced Sialorrhea (September)” View full resource at theannals.com
Most Recently Shared on August 19, 2011 at 3:50 am By:
Immediate-Release Oxybutynin for the Treatment of Clozapine-Induced Sialorrhea (September): OBJECTIVE:To describ... http://t.co/S27TpOe
Transdermal oxybutynin may improve work productivity | News | Nursing Times
nursingtimes.net — “A study on Transdermal oxybutynin has found that it may improve work productivity” View full resource at nursingtimes.net
Most Recently Shared on August 3, 2009 at 3:57 pm By:
News: Transdermal oxybutynin may improve work productivity http://bit.ly/1398QK
Propiverine better than oxybutynin for childhood urge incontinence | News | Nursing Times
nursingtimes.net — “Children tolerate propiverine better than oxybutynin for treatment of urge incontinence, according to a retrospective observational study conducted by researchers in Germany.” View full resource at nursingtimes.net
Most Recently Shared on January 15, 2010 at 5:24 am By:
News: Propiverine better than oxybutynin for childhood urge incontinence http://bit.ly/8R9lOg
FDA issues warning about medications containing oxybutynin : National MS Society
nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.” View full resource at nationalmssociety.org
Most Recently Shared on July 15, 2011 at 6:48 pm By:
News! FDA issues warning about medications containing oxybutynin http://bit.ly/nEx4oe
Upsher-Smith Labs Announces Expansion of Nationwide Recall on Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantovena and Oxybutynin
usrecallnews.com — “Upsher-Smith Laboratories, Inc., is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets. The tablets were found by a retail pharmacy to contain tablets at a higher, 10 mg strength.” View full resource at usrecallnews.com
Most Recently Shared on February 21, 2011 at 3:09 pm By:
Upsher-Smith Labs Announces Expansion of Nationwide Recall on Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, http://f.ast.ly/qebTD
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol®) - Drugs.com MedNews
drugs.com — “Late Stage Development Product Further Extends Watson s PARSIPPANY, N.J. and EWING, N.J., July 11, 2011 PRNewswire via Watson Pharmaceuticals, Inc. (NYSE WPI) a” View full resource at drugs.com
Most Recently Shared on July 11, 2011 at 1:02 pm By:
Drugs and Devices OW OW Health
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol®): La... http://bit.ly/rtBo64 #drug
Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall. Affected Products Include Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantoven® and Oxybutynin
fda.gov — “Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets to include additional products that were packaged on the same packaging line between May 17, 2010 and November 17, 2010. The company is initiating the recall as a precautionary measure after a bottle labeled as Jantoven® Warfarin Sodium, USP, 3 mg Tablets was found by a retail pharmacy to contain tablets at a higher, 10 mg str” View full resource at fda.gov
Most Recently Shared on February 19, 2011 at 6:22 pm By:
Ohio Family Practice Physician Group
Drug recall expanded to include: Amantadine, Amlodipine, Baclofen, Bethanechol, Jantoven® and Oxybutynin http://goo.gl/5hQnK
Gel effective for women with overactive bladder | Reuters
reuters.com — “CHICAGO (Reuters Health) - Applying a gel containing the anti-spasmodic agent oxybutynin to the skin is safe and effective for women with overactive bladder, according to a study reported here at the annual” View full resource at reuters.com
Most Recently Shared on May 5, 2009 at 3:50 pm By:
vumcnews Hospital and Healthcare System
InTheNews: Gel effective for women with overactive bladder - Reuters: Applying a gel containing the an.. http://tinyurl.com/dnxjox
FDA OKs First Overactive Bladder Gel Gelnique
webmd.com — “The FDA has approved Gelnique, the first and only topical gel to treat overactive bladder.” View full resource at webmd.com
Most Recently Shared on February 6, 2010 at 6:31 pm By:
FDA OKs First Overactive Bladder Gel Gelnique - http://short.to/164t7 #urinaryincontinence
Antares Pharma Announces Completion Of Patient Enrollment In Phase 3 Pivotal Trial Of Anturol™ For The Treatment Of Overactive Bladder
medicalnewstoday.com — “Antares Pharma, Inc. (NYSE Amex: AIS) announced that it has completed enrollment in the double-blind portion of the Company's Phase 3 clinical trial of Anturol™, its transdermal oxybutynin A” View full resource at medicalnewstoday.com
Most Recently Shared on March 4, 2010 at 4:12 pm By:
MNT Clinical Trials Health News
Antares Pharma Announces Completion Of Patient Enrollment In Phase 3 Pivotal Trial Of Anturol™ For The Treatment... http://mnt.to/3ysd
Urology Article | Urinary Bladder, Overactive
mdlinx.com — “Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome” View full resource at mdlinx.com
Most Recently Shared on August 25, 2011 at 10:18 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome: Amer... http://t.co/irvURRz #urology
Antares Pharma Announces Filing of New Drug Application for Anturol for Overactive Bladder
drugs.com — “Anturol (oxybutynin) is a new drug in development for the treatment of overactive bladder. Anturol information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on December 31, 2010 at 10:15 pm By:
Drugs and Devices OW OW Health
Antares Pharma Announces Filing of New Drug Application for Anturol for Overactive Bladder: EWING, N.J.--(... http://bit.ly/hVagOP #drug
Antares Pharma Announces FDA Acceptance of Anturol NDA for Filing
drugs.com — “Anturol (oxybutynin) is a new drug in development for the treatment of overactive bladder. Anturol information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on May 5, 2011 at 12:15 am By:
Drugs and Devices OW OW Health
Antares Pharma Announces FDA Acceptance of Anturol NDA for Filing: EWING, N.J.--(BUSINESS WIRE)--Apr 8, 20... http://bit.ly/iE4oV3 #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
The Annals
The Annals of Pharmacotherapy is a peer-reviewed medical journal advancing drug therapy by publishing evidence-based pharmacy research and clinical reviews.
Advertisement
